"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Descriptor ID |
D009369
|
| MeSH Number(s) |
C04
|
| Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1997 | 1 | 1 | 2 |
| 1998 | 3 | 0 | 3 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 1 | 2 |
| 2001 | 2 | 0 | 2 |
| 2002 | 2 | 2 | 4 |
| 2003 | 6 | 1 | 7 |
| 2004 | 10 | 3 | 13 |
| 2005 | 5 | 2 | 7 |
| 2006 | 12 | 1 | 13 |
| 2007 | 11 | 2 | 13 |
| 2008 | 12 | 1 | 13 |
| 2009 | 10 | 3 | 13 |
| 2010 | 14 | 5 | 19 |
| 2011 | 15 | 4 | 19 |
| 2012 | 14 | 8 | 22 |
| 2013 | 16 | 7 | 23 |
| 2014 | 20 | 3 | 23 |
| 2015 | 20 | 1 | 21 |
| 2016 | 33 | 2 | 35 |
| 2017 | 25 | 0 | 25 |
| 2018 | 23 | 4 | 27 |
| 2019 | 23 | 9 | 32 |
| 2020 | 41 | 2 | 43 |
| 2021 | 45 | 2 | 47 |
| 2022 | 28 | 1 | 29 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
Advances in Imaging of Inflammation, Fibrosis, and Cancer in the Gastrointestinal Tract. Int J Mol Sci. 2022 Dec 17; 23(24).
-
Immune Checkpoint Inhibitors: The Unexplored Landscape of Geriatric Oncology. Oncologist. 2022 Sep 02; 27(9):778-789.
-
Cancer-associated venous thromboembolism: Incidence and features in a racially diverse population. J Thromb Haemost. 2022 10; 20(10):2366-2378.
-
Venous thromboembolism as the first sign of malignancy. J Vasc Surg Venous Lymphat Disord. 2022 Nov; 10(6):1260-1266.
-
Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0]. BMC Public Health. 2022 07 15; 22(1):1359.
-
Single-cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing. Clin Transl Med. 2022 07; 12(7):e937.
-
EWI2 prevents EGFR from clustering and endocytosis to reduce tumor cell movement and proliferation. Cell Mol Life Sci. 2022 Jun 30; 79(7):389.
-
Trends and disparities in pulmonary embolism mortality among patients with cancer. Vasc Med. 2022 10; 27(5):493-495.
-
Financial Toxicity, Symptom Burden, Illness Perceptions, and Communication Confidence in Cancer Clinical Trial Participants. JCO Oncol Pract. 2022 09; 18(9):e1427-e1437.
-
Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation Program. J Clin Oncol. 2022 10 10; 40(29):3439-3452.